|
시장보고서
상품코드
1556576
인터벤셔널 종양 절제 시장 보고서 : 동향, 예측, 경쟁 분석(-2030년)Interventional Oncology Ablation Market Report: Trends, Forecast and Competitive Analysis to 2030 |
||||||
Lucintel
인터벤셔널 종양 절제의 동향 및 예측
세계의 인터벤셔널 종양 절제 시장은 2024년부터 2030년까지 CAGR 8.2%로 전망되며, 2030년까지 추정 9억 790만 달러에 달할 것으로 예측됩니다. 이 시장의 주요 촉진요인은 암 유병률의 상승과 절제에 대한 의식 증가입니다. 세계 인터벤셔널 종양 절제 시장의 미래는 병원 및 클리닉 시장과 외래수술센터(ASC) 시장의 기회에 의해 유망시되고 있습니다.
인터벤셔널 종양 절제의 부문별 전이
본 조사에서는 세계의 인터벤셔널 종양 절제 기술별, 적응증별, 최종 용도별, 지역별 예측을 제공합니다.
인터벤셔널 종양 절제 시장 인사이트
Lucintel은 예측 기간 동안 폐암이 가장 큰 부문인 것을 계속할 것으로 예측했습니다.
이 시장에서 병원 및 클리닉은 예측 기간 동안 계속 큰 부문입니다.
북미는 예측 기간 동안 가장 규모가 큰 지역으로 유지됩니다.
FAQ
Q1. 시장 규모는 :
A1. 세계의 인터벤셔널 종양 절제 시장은 2030년까지 추정 9억 790만 달러에 이를 것으로 예상됩니다.
Q2. 시장 성장 예측은 :
A2. 세계의 인터벤셔널 종양 절제 시장은 2024년부터 2030년까지 연평균 복합 성장률(CAGR) 8.2%로 성장할 것으로 예측됩니다.
Q3. 시장 성장에 영향을 미치는 주요 촉진요인은 :
A3. 이 시장의 주요 촉진요인은 암 유병률 상승과 절제에 대한 의식 증가입니다.
Q4. 시장의 주요 부문은 :
A4. 인터벤셔널 종양 절제 시장의 미래는 병원 및 진료소 시장과 외래수술센터(ASC) 시장에 기회가 있어 유망합니다.
Q5. 시장의 주요 기업은 :
A5. 인터벤셔널 종양 절제 주요 기업은 다음과 같습니다.
- Boston Scientific Corporation
- Johnson & Johnson
- Medtronic
- Varian Medical Systems
- EDAP TMS
- AngioDynamics
- CASCINATION
- Merit Medical Systems
- STARmed
- Biomedical
Q6. 향후 가장 큰 시장 부문은 :
A6. Lucintel은 예측 기간 동안 폐암이 가장 큰 부문으로 계속될 것으로 예측했습니다.
Q7. 시장에서 향후 5년간 최대가 될 것으로 예상되는 지역은 :
A7. 예측 기간 동안 북미는 최대 지역으로 계속됩니다.
Q8. 보고서 사용자 정의는 가능한가?
A8. 그렇습니다, Lucintel는 추가 비용 없이 10% 주문을 받아서 만듭니다.
목차
제1장 주요 요약
제2장 세계의 인터벤셔널 종양 절제 시장 : 시장 역학
- 서문, 배경 및 분류
- 공급망
- 업계의 촉진요인 및 과제
제3장 시장 동향 및 예측 분석(2018-2030년)
- 거시경제 동향(2018-2023년)과 예측(2024-2030년)
- 세계의 인터벤셔널 종양 절제 시장 동향(2018-2023년)과 예측(2024-2030년)
- 세계의 인터벤셔널 종양 절제 시장 : 기술별
- 고주파 절제
- 마이크로파 절제
- 동결요법
- 돌이킬 수없는 전기 천공 절제
- 세계의 인터벤셔널 종양 절제 시장 : 적응증별
- 간암
- 신장암
- 폐암
- 기타
- 세계의 인터벤셔널 종양 절제 시장 : 최종 용도별
- 병원 및 진료소
- 외래수술센터(ASC)
- 기타
제4장 시장 동향 및 예측 분석(2018-2023년) : 지역별
- 지역별 세계의 인터벤셔널 종양 절제 시장
- 북미의 인터벤셔널 종양 절제 시장
- 유럽의 인터벤셔널 종양 절제 시장
- 아시아태평양의 인터벤셔널 종양 절제 시장
- 기타 지역의 인터벤셔널 종양 절제 시장
제5장 경쟁 분석
- 제품 포트폴리오 분석
- 운영 통합
- Porter's Five Forces 분석
제6장 성장 기회 및 전략 분석
- 성장 기회 분석
- 기술별 세계 인터벤셔널 종양 절제 시장의 성장 기회
- 적응증별 세계 인터벤셔널 종양 절제 시장의 성장 기회
- 최종 용도별 세계 인터벤셔널 종양 절제 시장의 성장 기회
- 지역별 세계 인터벤셔널 종양 절제 시장의 성장 기회
- 세계 인터벤셔널 종양 절제 시장의 새로운 동향
- 전략 분석
- 신제품 개발
- 세계 인터벤셔널 종양 절제 시장의 능력 확대
- 세계 인터벤셔널 종양 절제 시장의 합병, 인수 및 합작 사업
- 인증 및 라이선싱
제7장 주요 기업의 기업 프로파일
- Boston Scientific Corporation
- Johnson & Johnson
- Medtronic
- Varian Medical Systems
- EDAP TMS
- AngioDynamics
- CASCINATION
- Merit Medical Systems
- STARmed
- Biomedical
Interventional Oncology Ablation Trends and Forecast
The future of the global interventional oncology ablation market looks promising with opportunities in the hospital & clinic and ambulatory surgical center markets. The global interventional oncology ablation market is expected to reach an estimated $907.9 million by 2030 with a CAGR of 8.2% from 2024 to 2030. The major drivers for this market are rising prevalence of cancer and growing awareness of ablation.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Interventional Oncology Ablation by Segment
The study includes a forecast for the global interventional oncology ablation by technology, indication, end use, and region.
Interventional Oncology Ablation Market by Technology [Shipment Analysis by Value from 2018 to 2030]:
- Radiofrequency Ablation
- Microwave Ablation
- Cryoablation
- Irreversible Electroporation Ablation
Interventional Oncology Ablation Market by Indication [Shipment Analysis by Value from 2018 to 2030]:
- Liver Cancer
- Kidney Cancer
- Lung Cancer
- Others
Interventional Oncology Ablation Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Others
Interventional Oncology Ablation Market by Region [Shipment Analysis by Value from 2018 to 2030]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of Interventional Oncology Ablation Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies interventional oncology ablation companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the interventional oncology ablation companies profiled in this report include-
- Boston Scientific Corporation
- Johnson & Johnson
- Medtronic
- Varian Medical Systems
- EDAP TMS
- AngioDynamics
- CASCINATION
- Merit Medical Systems
- STARmed
- Biomedical
Interventional Oncology Ablation Market Insights
Lucintel forecasts that lung will remain the largest segment over the forecast period.
Within this market, hospital & clinic will remain larger segment over the forecast period.
North America will remain the largest region over the forecast period.
Features of the Global Interventional Oncology Ablation Market
Market Size Estimates: Interventional oncology ablation market size estimation in terms of value ($M).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Interventional oncology ablation market size by technology, indication, end use, and region in terms of value ($M).
Regional Analysis: Interventional oncology ablation market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different technologies, indications, end uses, and regions for the interventional oncology ablation market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the interventional oncology ablation market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q1. What is the interventional oncology ablation market size?
Answer: The global interventional oncology ablation market is expected to reach an estimated $907.9 million by 2030.
Q2. What is the growth forecast for interventional oncology ablation market?
Answer: The global interventional oncology ablation market is expected to grow with a CAGR of 8.2% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the interventional oncology ablation market?
Answer: The major drivers for this market are rising prevalence of cancer and growing awareness of ablation.
Q4. What are the major segments for interventional oncology ablation market?
Answer: The future of the interventional oncology ablation market looks promising with opportunities in the hospital & clinic and ambulatory surgical center markets.
Q5. Who are the key interventional oncology ablation market companies?
Answer: Some of the key interventional oncology ablation companies are as follows:
- Boston Scientific Corporation
- Johnson & Johnson
- Medtronic
- Varian Medical Systems
- EDAP TMS
- AngioDynamics
- CASCINATION
- Merit Medical Systems
- STARmed
- Biomedical
Q6. Which interventional oncology ablation market segment will be the largest in future?
Answer: Lucintel forecasts that lung will remain the largest segment over the forecast period.
Q7. In interventional oncology ablation market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
- Q.1. What are some of the most promising, high-growth opportunities for the interventional oncology ablation market by technology (radiofrequency ablation, microwave ablation, cryoablation, and irreversible electroporation ablation), indication (liver cancer, kidney cancer, lung cancer, and others), end use (hospitals & clinics, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
- Q.2. Which segments will grow at a faster pace and why?
- Q.3. Which region will grow at a faster pace and why?
- Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
- Q.5. What are the business risks and competitive threats in this market?
- Q.6. What are the emerging trends in this market and the reasons behind them?
- Q.7. What are some of the changing demands of customers in the market?
- Q.8. What are the new developments in the market? Which companies are leading these developments?
- Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
- Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
- Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
Table of Contents
1. Executive Summary
2. Global Interventional Oncology Ablation Market : Market Dynamics
- 2.1: Introduction, Background, and Classifications
- 2.2: Supply Chain
- 2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
- 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
- 3.2. Global Interventional Oncology Ablation Market Trends (2018-2023) and Forecast (2024-2030)
- 3.3: Global Interventional Oncology Ablation Market by Technology
- 3.3.1: Radiofrequency Ablation
- 3.3.2: Microwave Ablation
- 3.3.3: Cryoablation
- 3.3.4: Irreversible Electroporation Ablation
- 3.4: Global Interventional Oncology Ablation Market by Indication
- 3.4.1: Liver Cancer
- 3.4.2: Kidney Cancer
- 3.4.3: Lung Cancer
- 3.4.4: Others
- 3.5: Global Interventional Oncology Ablation Market by End Use
- 3.5.1: Hospitals & Clinics
- 3.5.2: Ambulatory Surgical Centers
- 3.5.3: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
- 4.1: Global Interventional Oncology Ablation Market by Region
- 4.2: North American Interventional Oncology Ablation Market
- 4.2.1: North American Interventional Oncology Ablation Market by Indication: Liver Cancer, Kidney Cancer, Lung Cancer, and Others
- 4.2.2: North American Interventional Oncology Ablation Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
- 4.3: European Interventional Oncology Ablation Market
- 4.3.1: European Interventional Oncology Ablation Market by Indication: Liver Cancer, Kidney Cancer, Lung Cancer, and Others
- 4.3.2: European Interventional Oncology Ablation Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
- 4.4: APAC Interventional Oncology Ablation Market
- 4.4.1: APAC Interventional Oncology Ablation Market by Indication: Liver Cancer, Kidney Cancer, Lung Cancer, and Others
- 4.4.2: APAC Interventional Oncology Ablation Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
- 4.5: ROW Interventional Oncology Ablation Market
- 4.5.1: ROW Interventional Oncology Ablation Market by Indication: Liver Cancer, Kidney Cancer, Lung Cancer, and Others
- 4.5.2: ROW Interventional Oncology Ablation Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
5. Competitor Analysis
- 5.1: Product Portfolio Analysis
- 5.2: Operational Integration
- 5.3: Porter's Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
- 6.1: Growth Opportunity Analysis
- 6.1.1: Growth Opportunities for the Global Interventional Oncology Ablation Market by Technology
- 6.1.2: Growth Opportunities for the Global Interventional Oncology Ablation Market by Indication
- 6.1.3: Growth Opportunities for the Global Interventional Oncology Ablation Market by End Use
- 6.1.4: Growth Opportunities for the Global Interventional Oncology Ablation Market by Region
- 6.2: Emerging Trends in the Global Interventional Oncology Ablation Market
- 6.3: Strategic Analysis
- 6.3.1: New Product Development
- 6.3.2: Capacity Expansion of the Global Interventional Oncology Ablation Market
- 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Interventional Oncology Ablation Market
- 6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
- 7.1: Boston Scientific Corporation
- 7.2: Johnson & Johnson
- 7.3: Medtronic
- 7.4: Varian Medical Systems
- 7.5: EDAP TMS
- 7.6: AngioDynamics
- 7.7: CASCINATION
- 7.8: Merit Medical Systems
- 7.9: STARmed
- 7.10: Biomedical
